Skip to main content
Caplight Logo









Humigent

Humigent

Private
Iselin, New JerseyHealthcare & Life Scienceshttps://humigent.ai/

Last Round

Series A

Jul 29, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Humigent operates in Healthcare & Life Sciences and is based in Iselin, New Jersey. Its latest recorded funding round was a Series A round in July 2026.

Humigent is an AI-native company that provides agentic AI and advanced analytics solutions specifically designed for pharmaceutical and biotechnology organizations.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Business Intelligence, NLP & Conversational AI, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Humigent Comparables

Compare Humigent with similar companies based on industry and business-model similarity.

Humigent comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sorcero
82%
TikaMobile
77%
PharmaForceIQ
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Humigent Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 29, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Humigent Investors

Notable investors and investment history

Humigent investors
InvestorRounds
Z21 VenturesSeries A
First Rays Venture PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Raised Series A with participation from First Rays Venture Partners and Z21 Ventures.

Book a demo to see all signals

For institutional investors. Book with your work email.

Humigent Filings

Explore SEC and related filing metadata, where available.

Humigent filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Humigent's valuation, stock price, and market status.

Is Humigent a public or private company?

Humigent is a private company.

What is the current stock price of Humigent?

Humigent is a private company, so its shares have no public market price. Caplight tracks Humigent's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Humigent worth (valuation)?

Valuation information for Humigent is not publicly available.

Can I buy Humigent stock?

Humigent shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Humigent's last funding round?

Humigent's most recent funding round was Series A on July 29, 2026.

Who are the main investors in Humigent?

Key investors in Humigent include Z21 Ventures, First Rays Venture Partners.

Will Humigent IPO soon?

No public IPO plans have been announced for Humigent.

How can I track Humigent secondary market activity?

Caplight tracks bids, offers, and trades in Humigent's shares on secondary markets.

Firmographic Details

HeadquartersIselin, New Jersey
Year Founded2025
Last FundingJul 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?